amyotrophic lateral sclerosis (ALS) Archive — Page 1 of 1

A woman speaks at a microphone before an audience, with a projected presentation titled “ALS at Vanderbilt” behind her. Blue, white, and gold balloon arrangements flank the presentation area.

June 17, 2026

Vanderbilt ALS Research Center receives $11 million in funding from Tennessee General Assembly

The investment marks a major public commitment to research on the life-altering neurodegenerative disease.

Audience members, including a person using a powered wheelchair, watch a presenter and a projected presentation about genes in a decorated meeting room.

June 1, 2026

Vanderbilt ALS Research Center hosts second Reporting the Research event

Attendees gathered at Fat Bottom Brewing Company on May 20 for the event to raise awareness about the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS).

By Evan Dorian

Group of community members and Vanderbilt ALS Research Center staff pose in a hospital lobby with an oversized check for $18,500 from the TShaw 5K to Beat ALS; the check is dated 3/2/2026.

April 10, 2026

Vanderbilt ALS Research Center receives gift from TShaw Strong 5K to Beat ALS

The funding will support research efforts aimed at finding a cure for the progressive neurodegenerative disease ALS (amyotrophic lateral sclerosis).

By Evan Dorian

March 25, 2024

Brain atlas pinpoints vulnerabilities in ALS and dementia

By Paul Govern

November 20, 2023

Belzil to establish VUMC ALS Research Center

Neuroscientist Véronique Belzil, PhD, MS, will join Vanderbilt University Medical Center as associate professor of Neurology and director of ALS (amyotrophic lateral sclerosis) research.

By Paul Govern

Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.

September 23, 2021

Local family shines in campaign to establish ALS research program

Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

By Paul Govern

May 6, 2021
Study finds that regulatory protein prevents signaling that triggers cell death

A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered.
By Leigh MacMillan
July 30, 2020
Protein study may be key to treating fibrotic diseases

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.
By Bill Snyder

amyotrophic lateral sclerosis (ALS) Archive — Page 1 of 1

Vanderbilt ALS Research Center receives $11 million in funding from Tennessee General Assembly

Vanderbilt ALS Research Center hosts second Reporting the Research event

Vanderbilt ALS Research Center receives gift from TShaw Strong 5K to Beat ALS

Brain atlas pinpoints vulnerabilities in ALS and dementia

Belzil to establish VUMC ALS Research Center

Local family shines in campaign to establish ALS research program

Study finds that regulatory protein prevents signaling that triggers cell death

Protein study may be key to treating fibrotic diseases